ALLR — Allarity Therapeutics Balance Sheet
0.000.00%
- $3.75m
- $7.64m
Annual balance sheet for Allarity Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.58 | 0.366 | 19.6 | 2.08 | 0.222 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.33 | 1.07 | 1.34 | 0.871 | 0.946 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.34 | 1.72 | 21.1 | 4.97 | 1.97 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.437 | 0.352 | 0.094 | 0.027 | 0.02 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 31.6 | 33.4 | 49.6 | 14.5 | 11.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.72 | 5.53 | 20.7 | 11.2 | 14.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 13.5 | 8.96 | 30.8 | 12.7 | 14.6 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 18.1 | 24.4 | 18.8 | 1.89 | -2.75 |
Total Liabilities & Shareholders' Equity | 31.6 | 33.4 | 49.6 | 14.5 | 11.9 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |